Oxbryta Lawsuit in Washington D.C.

Oxbryta Lawsuit in Washington D.C.: Fighting for Those Harmed

Oxbryta was developed to treat anemia in Sickle Cell Disease (SCD) patients by improving hemoglobin levels and reducing the effects of sickled red blood cells. However, in September 2024, Pfizer issued a voluntary recall of the drug worldwide following alarming post-market trial data.

The findings revealed that Oxbryta posed severe health risks, including an increased likelihood of vaso-occlusive crises (VOC), organ damage, and even fatal complications.

If you or someone close to you took Oxbryta and experienced serious health effects, you may qualify for an Oxbryta lawsuit against Pfizer Inc. At Rueb Stoller Daniel, we are committed to helping victims in Washington D.C., Maryland, Virginia, and nationwide seek justice. Contact us today for a free case evaluation.

What Is Oxbryta (Voxelotor)?

Voxelotor, sold under the brand name Oxbryta, was a prescription medication to treat sickle cell disease. It was developed by Global Blood Therapeutics and approved by the FDA in 2019.

In 2022, Pfizer acquired Global Blood Therapeutics. After numerous reports of dangerous side effects and fatal reactions, Pfizer decided to recall Oxbryta on September 25, 2024.

The Oxbryta Recall: What You Need to Know

On September 25, 2024, Pfizer voluntarily recalled Oxbryta following troubling study results.

The drug, designed to treat anemia in Sickle Cell Disease (SCD) patients, was linked to a higher risk of vaso-occlusive crises (VOCs), organ damage, and death. In the Hope Kids 2 trial of 236 children, eight deaths were reported in those taking Oxbryta, while only two deaths occurred in the placebo group. Similarly, the RESOLVE study, which focused on sickle cell patients with leg ulcers, also recorded eight deaths.

With these alarming findings and increased VOC episodes, Pfizer pulled Oxbryta from the market worldwide to ensure patient safety. Our blog provides a detailed analysis of Oxbryta’s global recall.

If you believe you’ve been affected by this recalled medication, don’t wait—reach out to our Oxbryta injury lawyers for a free case review.

sickle cell disease awareness ribbon

Oxbryta’s Purpose: Treating Sickle Cell Disease

Sickle cell disease (SCD) is a hereditary condition that affects the shape and function of red blood cells. Instead of being flexible and round, the cells become rigid and sickle-shaped, making it difficult for them to flow freely through blood vessels. This can lead to oxygen deprivation and severe health risks.

Serious complications of sickle cell disease include:

  • Infections due to reduced immune function.
  • Acute Chest Syndrome: A dangerous condition in which sickle cells obstruct blood flow to the lungs.
  • Stroke: Sickled cells increase the risk of blood clotting.
  • Organ failure resulting from chronic oxygen deprivation.
  • Vaso-occlusive crises (VOCs): Painful episodes caused by blocked blood circulation.
  • Hemolytic anemia: Without enough healthy red blood cells, patients experience fatigue and weakness.

Historically, sickle cell treatments have focused on managing pain and complications through transfusions and symptom relief. Oxbryta, developed by Global Blood Therapeutics (GBT), was introduced as a treatment aimed at addressing the underlying cause—abnormal hemoglobin.

Hemoglobin is the protein in red blood cells that transports oxygen throughout the body. In people with SCD, defective hemoglobin causes red blood cells to become misshapen. Oxbryta was designed to improve hemoglobin’s ability to bind to oxygen. It was meant to prevent cell sickling, enhance circulation, and reduce complications.

Oxbryta Side Effects and Complications

Nausea, diarrhea, and headaches are among the most commonly reported side effects of Oxbryta. However, some individuals have also experienced serious allergic reactions.

Due to its association with severe health complications, Oxbryta was recalled. Lawsuits claim that Global Blood Therapeutics (GBT) and Pfizer did not provide sufficient warnings about safety concerns.

Vaso-Occlusive Crises (VOC)

Oxbryta can cause increased vaso-occlusive crises (VOCs), also known as sickle cell crises. These crises occur when sickle-shaped red blood cells obstruct blood flow in small vessels, depriving tissues and organs of oxygen. This can cause excruciating pain and lasting damage.

Common symptoms of a vaso-occlusive crisis include intense pain, swelling in the hands or feet, fever, and symptoms of severe dehydration. These painful episodes can last anywhere from several hours to multiple days. In addition to intense pain, recurrent VOCs can result in life-threatening complications.

Possible complications include:

  • Acute chest syndrome
  • Stroke
  • Organ failure, including kidney dysfunction
  • Pulmonary embolism

Serious Health Risks and Death

Oxbryta has been connected to severe complications, including fatal outcomes. In clinical trials after the drug was released, researchers found more deaths occurred among Oxbryta users compared to those receiving a placebo.

The drug may heighten the risk of:

  • Organ failure, such as kidney or liver damage
  • Heart attack and stroke

If you experience complications, keep a detailed record of your medical history and symptoms.

Who Is Eligible for an Oxbryta Lawsuit in Washington D.C.?

If you or a loved one have experienced severe health complications after using Oxbryta, you may be able to seek compensation. At Rueb Stoller Daniel, we are dedicated to helping individuals who have suffered harm due to dangerous or defective drugs. To qualify for an Oxbryta lawsuit in Washington D.C., individuals must meet the following criteria:

  • Usage Requirements: You must have taken Oxbryta for at least 30 days.
  • Complications After Oxbryta Use:
    • Increased Vaso-Occlusive Crises (VOC)
    • Stroke
    • Heart Attack
    • Organ Failure (e.g., kidney or liver failure)
    • Death

If you experienced complications or lost a family member, our team can help you pursue justice and compensation. Contact Rueb Stoller Daniel today for a free case evaluation and to discuss your legal options.

Who can file an Oxbryta lawsuit in Washington DC?

Oxbryta Lawsuit Compensation: What You May Be Entitled To

Individuals who have suffered harm due to Oxbryta’s side effects may qualify for financial compensation. A lawsuit can help recover medical expenses, lost wages, pain and suffering, and other damages related to the drug’s impact. At Rueb Stoller Daniel, we are committed to securing the maximum compensation for those affected.

Medical Expenses

Medical care for Oxbryta complications can be costly, and victims may recover expenses for:

  • Emergency Treatment – Sudden and severe reactions like strokes or heart attacks often require urgent, expensive care.
  • Hospitalization – Extended stays due to organ failure or other health complications can result in overwhelming medical bills.
  • Ongoing Treatments – Long-term care, such as dialysis for kidney failure or rehabilitation for stroke recovery, may be necessary.
  • Prescription Costs – Additional medications may be needed to manage new conditions caused by Oxbryta.
  • Future Healthcare Needs – If chronic conditions develop, compensation can include projected medical costs for ongoing treatment.

Lost Wages and Career Impact

Individuals who suffer severe side effects from Oxbryta may be unable to work. Compensation may include:

  • Lost Income – Lost wages lost due to time away from work for treatment and recovery.
  • Reduced Earning Ability – You may seek damages for lost future earnings if Oxbryta side effects stop you from working or limit your career.

Pain and Suffering

Oxbryta’s side effects can cause significant distress, both physically and emotionally. Non-economic damages may cover:

  • Physical Pain – Severe pain from increased vaso-occlusive crises (VOCs) or organ failure.
  • Emotional Trauma – Anxiety, depression, or PTSD related to the health issues caused by Oxbryta.
  • Loss of Quality of Life – Compensation for individuals who can no longer participate in hobbies or activities they once enjoyed.

Other Finacial Costs

You may also seek reimbursement for:

  • Travel Expenses – Cost of traveling to and from medical appointments.
  • Home Renovations – Modifications like wheelchair ramps to accommodate a disability.
  • Caregiver Costs – Compensation for professional in-home care or financial losses by family members who must leave their jobs to provide care.

Impact on Family Relationships

An Oxbrya lawsuit can include compensation for loss of companionship, support, and intimacy with your spouse due to your injuries.

Wrongful Death Compensation

Families who have lost a loved one due to Oxbryta complications may pursue a wrongful death claim for:

  • Funeral and burial expenses
  • Loss of financial support from the deceased
  • Loss of companionship and emotional support

Punitive Damages

If the drug manufacturer was particularly negligent, victims may seek punitive damages. Courts award these damages to punish the responsible party.

If you or a loved one has been harmed by Oxbryta, Rueb Stoller Daniel is here to help. Contact us today for a free consultation to discuss your legal options.

Filing an Oxbryta Lawsuit in Washington D.C.

If you or someone you love has suffered serious health problems linked to Oxbryta, you may qualify for compensation. At Rueb Stoller Daniel, we understand the challenges of a lawsuit and are here to help Washington D.C. residents every step of the way.

What You Need to Prove Your Case

Strong evidence is essential. Our attorneys will work with you to gather:

  • Medical Records – Documents showing Oxbryta use and its effects.
  • Doctor and Pharmacy Communications – Any warnings (or lack of warnings) about the drug.
  • Side Effect Reports – Complaints made to the FDA or medical professionals.
  • Expert Testimony – Doctors who can testify about Oxbryta’s risks.

It’s important to act quickly to secure evidence for an Oxbryta lawsuit. Contact us today to get started.

Settlements vs. Trials

Most defective drug lawsuits are settled before trial. However, if your case goes to court, our Washington D.C. Oxbryta attorneys will provide aggressive legal representation to fight for the best outcome.

Washington D.C. Oxbryta lawyer

What Is the Deadline for an Oxbryta Lawsuit in DC?

If you want to file an Oxbryta lawsuit in Washington D.C., the law gives you a limited time to do so. If you miss the deadline, you may lose your right to seek compensation.

Under DC Law Code § 12–301, the District of Columbia has a three-year statute of limitations for personal injury cases. This means you generally have three years to file a lawsuit after being harmed.

However, there are exceptions to this rule. The discovery rule applies to Oxbryta cases where patients don’t learn about health problems immediately. This means the three-year clock starts ticking when you discovered or reasonably should have discovered your injury.

You should contact a DC Oxbryta lawyer as soon as possible to protect your rights.

Time Limits for Oxbryta Cases in Maryland and Virginia

Maryland has strict time limits for product liability cases, including defective drugs like Oxbryta. Victims must file an Oxbryta lawsuit within three years of the injury or two years of discovering the injury, whichever comes first.

Virginia has a two-year statute of limitations for personal injury cases (Virginia Code § 8.01-243). Unlike most states, Virginia doesn’t have a discovery rule except for asbestos, breast implants, and implanted medical devices. This means you must file an Oxbryta lawsuit in Virginia within two years of your injury, not two years from when you learned about the injury.

Don’t wait to seek legal guidance. Contact our DC Oxbryta lawyers at Rueb Stoller Daniel today.

How Much Does a Washington D.C. Oxbryta Lawyer Cost?

At Rueb Stoller Daniel, we handle Oxbryta cases on a contingency fee basis. This means you pay nothing upfront, and we only receive a fee if we win your case. Your lawyer’s payment is a percentage of your final settlement or court award.

Why Choose Rueb Stoller Daniel?

At Rueb Stoller Daniel, we’re here to help you navigate the legal process and fight for the maximum compensation. We give your case personalized attention, treating you like a person, not just a file number.

  • Experience: Gregory Rueb, Paul Stoller, and Stephen Daniel have over fifty years of combined experience. Our team has represented tens of thousands of clients across the country.
  • Results: We have recovered hundreds of millions of dollars for clients.
  • Reputation: Our law firm has earned a variety of awards and memberships.

Call Today for a Free Case Review

At Rueb Stoller Daniel, we understand the challenges patients with sickle cell disease face and the risks associated with Oxbryta. If you or a loved one has suffered due to Oxbryta, don’t wait to take action. Contact us today to schedule your free consultation.

You can reach us by calling 1-866-CALL-RSD or filling out our online form. We are available 24/7.